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OBJECTIVES We examined whether common coronary heart disease (CHD) risk factors measured in
mid-life predict erectile dysfunction (ED) 25 years later.
BACKGROUND Retrospective and cross-sectional studies have suggested that ED is associated with classic
CHD risk factors, but few prospective studies have studied these associations.
METHODS In this prospective study of community-dwelling men age 30 to 69 years, seven classic CHD
risk factors (age, smoking, hypertension, diabetes, hypercholesterolemia, hypertriglyceride-
mia, and obesity) were assessed from 1972 to 1974. In 1998, after an average follow-up of 25
years, surviving male participants were asked to complete the International Index of Erectile
Function (IIEF-5), which allows stratification of ED into five groups.
RESULTS Sixty-eight percent of the surviving men returned, and 60% completed the IIEF-5
questionnaire. Respondents had more favorable levels of all heart disease risk factors at
baseline than non-respondents. At baseline, the average age of the 570 ED study participants
was 46 years; at follow-up, their average age was 72 years. Mean age, body mass index,
cholesterol, and triglycerides were each significantly associated with an increased risk of ED.
Cigarette smoking was marginally more common in those with severe/complete ED, as
compared with those without ED. Blood pressure and fasting blood glucose were not
significantly associated with ED, likely due to selective mortality.
CONCLUSIONS Improving CHD risk factors in mid-life may decrease the risk of ED as well as CHD.
Erectile dysfunction should be included as an outcome in clinical trials of lipid-lowering
agents and lifestyle modifications. (J Am Coll Cardiol 2004;43:1405–11) © 2004 by the
American College of Cardiology Foundationn
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according to the National Institutes of Health, erectile
ysfunction (ED), the persistent inability to attain and
aintain a penile erection adequate for satisfactory sexual
erformance, affects 30 million men in the U.S. alone (1). In
ecent years, the emphasis on the likely etiology of ED has
hifted from psychogenic causes to those of vascular origin
2,3)—based largely on retrospective and cross-sectional
tudies of patients (4–7). These studies showed that ED is
ssociated with many coronary heart disease (CHD) risk
actors, including diabetes mellitus (4,6,7), hypertension
4,6,7), smoking (4,5,7), and abnormal lipids (5,6). It has
een suggested that ED may be a clinical marker of
oronary, peripheral, or cerebrovascular disease as well as
ypertension and diabetes (8,9). Small studies have linked
D with angiographic evidence of coronary disease (10,11).
ne study of 132 men correlated angiographic results with
D symptoms and scores on the 5-item International Index
f Erectile Function (IIEF-5); 58% reported experiencing
D before the diagnosis of CHD (11). To our knowledge,
From the *Department of Internal Medicine, University of California, San Diego;
nd †Division of Epidemiology, Department of Family and Preventive Medicine,
niversity of California San Diego, La Jolla, California. This research was supported
y grants from the National Institute of Diabetes and Digestive and Kidney Diseases
grant DK-31801), the National Institute on Aging (grant AG-07181), and the
ational Heart, Lung, and Blood Institute (grant U01-HL40154). Melvin D.
heitlin, MD, acted as Guest Editor for this paper.
Manuscript received July 17, 2003; revised manuscript received November 7, 2003,ccepted November 20, 2003.o studies have reported the degree to which mid-life heart
isease risk factors predict ED 25 years later.
We report here a prospective study of common CHD risk
actors assessed in men age 30 to 69 years from 1972 to 1974
nd ED by the IIEF-5, as reported by 60% of the surviving
ohort in 1998.
ETHODS
etween 1972 and 1974, 82% of adult residents of Rancho
ernardo, California, a planned community of predomi-
antly middle-class to upper middle-class Caucasian adults,
articipated in a survey of CHD risk factors. The baseline
linical evaluation included a brief medical and medication
istory and measurement of height, weight, blood pressure
BP), fasting plasma glucose (FPG), cholesterol, and tri-
lyceride levels. High-density lipoprotein cholesterol was
ot measured. Systolic blood pressure (SBP) and diastolic
lood pressure (DBP) were measured in seated, rested
ubjects, using a standard protocol; height and weight were
easured with subjects wearing light clothing and no shoes.
asting plasma cholesterol and triglycerides were measured
n a Centers for Disease Control-certified lipid research
linic laboratory, using an Auto Analyzer I (Technicon
nstruments, Tarrytown, New York). Fasting plasma cho-
esterol was measured by a hexokinase method in a clinical
aboratory. Body mass index (BMI) (kg/m2) was calculated
s an estimate of obesity.Baseline hypertension was defined as SBP140 mm Hg,
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CHD Risk Factors Predict ED April 21, 2004:1405–11BP 90 mm Hg, use of BP medications, or a history of
igh BP; diabetes mellitus as FPG 7.0 mmol/l (126 mg/
l), use of diabetes medications, or a personal history of
iabetes; hypercholesterolemia as fasting total cholesterol
5.2 mmol/l (200 mg/dl), use of medication for cholesterol,
r a history of high cholesterol; hypertriglyceridemia as a
asting triglyceride level 2.6 mmol/l (200 mg/dl); and
besity as BMI 28 kg/m2.
In 1998, all surviving non-institutionalized men were
nvited to complete a mailed questionnaire that included the
hort 5-item ED questionnaire (IIEF-5). Of 944 surviving
embers of the original cohort of 1,810 men age 30 to 69
ears at baseline, 641 returned the survey (response rate
7.9%). Of these, 71 were excluded for incomplete re-
ponses to questions, leaving 570 men for this report. The
ain reason (74.1%) for non-response was death before the
998 questionnaire (Fig. 1).
The IIEF is a widely accepted international standard for
linical trials involving sexual function, with four domains
omposing a multidimensional 15-item questionnaire
Abbreviations and Acronyms
BMI  body mass index
BP  blood pressure
CHD  coronary heart disease
CI  confidence interval
DBP  diastolic blood pressure
ED  erectile dysfunction
FPG  fasting plasma glucose
IIEF-5  5-item International Index of Erectile
Function
MMAS  Massachusetts Male Aging Study
OR  odds ratio
SBP  systolic blood pressureaFigure 1. Flow chart of study participants. ED  erectile dysfunction.12,13). The IIEF-5 questionnaire is an abbreviated form of
he IIEF, used to classify ED, with four items selected from
he erectile domain portion of the IIEF and one addressing
exual satisfaction (14). The IIEF-5 has been validated
14,15) and correlated with patient reports of ED (15). The
rectile function domain score is calculated as the sum of
uestions 1 through 4 for men with complete answers to the
IEF-5. The degree of ED is classified by the erectile
unction domain score as complete (4), severe (5 to 10),
oderate (11 to 14), mild (15 to 18), or none (19 to 20).
he IIEF-5 protocol (Table 1) does not categorize men
ho fail to provide complete responses or report “no sexual
ctivity” as a response to any of the questions on the IIEF-5
uestionnaire.
Statistical analyses were performed using Statistical Anal-
sis System software (SAS Institute, Cary, North Carolina).
he internal consistency of the questionnaire construct was
onfirmed with a Cronbach’s alpha coefficient of 0.96 for all
ve questions and 0.95 for the four erectile function
uestions.
All baseline measures, except triglyceride levels, were
ufficiently normally distributed so that transformation was
nnecessary. For triglyceride levels, log-transformed values
ere used, with the values returned to original units for
resentation. For continuous variables, the overall F statistic
rom general linear model procedures was used to determine
hether the age-adjusted mean values differed significantly
rom each other across ED categories. Age-adjusted indi-
idual mean comparisons were assessed using analysis of
ovariance with linear contrasts across ED categories. Chi-
quare statistics were used to determine whether age-
djusted values for categorical variables differed significantly
cross ED categories. Age-adjusted proportions were com-
uted by estimating probabilities for the ED groups at the
verall average age by logistic regression. The end points of
he 95% confidence intervals were computed based on
ethods described by Hosmer and Lemeshow (16).
Stepwise logistic regression was used to assess the rela-
ionship between age and the categorical risk factors (hy-
ertension, diabetes, hypercholesterolemia, hypertriglyceri-
emia, ever smoker, and obesity) and ED until a final model
as reached. Significance was p  0.05 for the odds ratio.
tepwise logistic regression was also used to estimate a
umulative logit model to predict the odds of being in a
ore severe ED category. Statistical significance was set at
 0.05 (two-sided).
ESULTS
f 1,810 men age 30 to 69 years at the baseline visit
etween 1972 and 1974, 48% (n  994) had died by the
ime of the 1998 ED questionnaire. Figure 1 shows the
7.9% response rate among survivors, 570 of whom com-
leted all of the IIEF-5 questions. Table 2 compares the
aseline characteristics of the study sample included in this
nalysis with men not included due to death, lost to
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April 21, 2004:1405–11 CHD Risk Factors Predict EDollow-up, or not answering all IIEF-5 questions. The mean
ges for those deceased, lost to follow-up, and with incom-
lete questionnaires were 61.8  7.4 years, 48.3  12.2
ears, and 50.9  10.6 years, respectively, compared with
5.6 10.2 years for respondents. At baseline, non-
espondents to IIEF-5 were less likely to be married, less
ikely to have completed one year of college, and more likely
o be past smokers (p  0.05). Levels of FPG, SBP, DBP,
otal cholesterol, and BMI were each significantly more
avorable in the ED study sample (p  0.05).
At baseline, the mean (SD) age of respondents was 45.6
10.2 years (range 30 to 69 years), with 63% being 50
ears of age. Age showed a strong linear correlation with
Table 2. Baseline Characteristics for Men in th
Non
(n
Mean  SD values
Age (yrs) 5
Fasting plasma glucose (mmol/l)
Total cholesterol (mmol/l)
Systolic blood pressure (mm Hg) 13
Diastolic blood pressure (mm Hg) 8
Body mass index (kg/m2) 2
Triglycerides (mmol/l)
Percentages
Married
1 year of college
Current smoking
Past smoking
able 1. 5-Item International Index of Erectile Function (IIEF-5
. How do you rate your confidence that you can get and keep an erection
Very low Low
1 2
. With sexual stimulation, how often have your erections been sufficient t
’m not at all
sexually active.
Almost never/never Rarely (much less than
half the time)
O
0 1 2
. During sexual intercourse, how often were you able to maintain an erec
’m not at all
sexually active.
Almost never/never Rarely (much less than
half the time)
O
0 1 2
. During sexual intercourse, how difficult has it been to maintain your ere
haven’t tried to
have sexual
intercourse.
Extremely difficult Very difficult
0 1 2
. When you attempted sexual intercourse, how often was it satisfactory to
’m not at all
sexually active.
Almost never/never Rarely (much less than
half the time)
O
0 1 2
All questions preceded by “over the past six months.” Reproduced by permission fr*Deceased, lost to follow-up, or missing responses.D (p  0.00001), with increasing severity, as shown in
igure 2. Nearly all (99.1%) were married and living with
heir spouses. Medication use was uncommon, with only 4%
eporting BP medication, 2% lipid-lowering medication,
nd 1% diabetes medication. At baseline, 2.6% reported
eart disease (40% in the sexually inactive group) and 2.1%
history of diabetes (42% in the sexually inactive group).
he average (SD) duration of follow-up was 25.4  0.57
ears (range 24.3 to 26.9 years), and the average age at
ollow-up was 71.5  10.3 years (range 54.7 to 95.6 years).
Table 3 shows age-adjusted CHD risk factors by ED
ategory or absent sexual activity. Age-adjusted, positive
inear trends as ED severity progressed from no ED to
ncho Bernardo Study, 1972 to 1974
nders*
240)
Our Sample
(n  570) p Value
10.8 45.6  10.2 0.0001
1.3 6.0  1.2 0.0023
0.9 5.3  0.9 0.0006
21.3 122.5  14.5 0.0001
11.4 77.9  9.8 0.0001
3.1 25.7  2.7 0.0489
1.3 0.3686
99.1 0.0219
87.2 0.0001
25.0 0.9268
42.3 0.0067
oderate High Very high
3 4 5
w for penetration (entering your partner)?
onally (about
the time)
Most of the time (much
more than half the time)
Almost always/always
3 4 5
fter penetration?
onally (about
the time)
Most of the time (much
more than half the time)
Almost always/always
3 4 5
s until completion of intercourse?
Difficult Slightly difficult Not difficult
3 4 5
onally (about
the time)
Most of the time (much
more than half the time)
Almost always/always
3 4 5
sen et al. (14).e Ra
respo
 1,
7.9 
6.2 
5.5 
7.0 
2.1 
6.0 
1.3
97.5
76.3
25.2
49.1)*
?
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CHD Risk Factors Predict ED April 21, 2004:1405–11evere/complete ED and no sexual activity were significant
or triglycerides (p  0.01) and for BMI (p  0.01). In
ge-adjusted analyses, men without ED had lower choles-
erol levels than men with moderate ED (p  0.05), and
en with severe/complete ED or who were not sexually
ctive had higher triglyceride levels than men without ED
p  0.05). Men with mild ED had lower triglyceride levels
han sexually inactive men (p  0.05). Age-adjusted base-
ine BMI was also significantly lower in men without ED
han in men with severe/complete ED or with sexually
nactive men (p  0.05).
The overall prevalence of categorically defined CHD risk
actors at baseline was 58% for hypercholesterolemia, 25%
or current cigarette smoking, 25% for hypertension, 18%
or being overweight, 15% for hypertriglyceridemia, and
2% for diabetes. Age-adjusted categorical CHD risk fac-
ors were assessed in bivariate and multivariate analyses.
ith marginal significance, men with hypercholesterolemia
t baseline were more likely to have moderate ED than no
D at follow-up, and men with severe/complete ED were
ore likely to have been current smokers at baseline than
hose without ED.
Multivariate analyses for age and all categorical risk
actors (diabetes, hypertension, hypercholesterolemia, hy-
able 3. Age-Adjusted Mean Heart Disease Risk Factors by Ere
972 to 1974
Cat
None
(n  129)
Mild
(n  119)
ge (yrs) 38.1  0.6 43.4  0.9
asting plasma glucose (mmol/l) 6.0  0.1 6.0  0.1
otal cholesterol (mmol/l) 5.2  0.1 5.4  0.1
riglycerides (mmol/l) 1.2 1.2
BP (mm Hg) 123.3  1.3 122.7  1.3
BP (mm Hg) 77.8  0.9 78.1  0.9
ulse pressure (SBP  DBP) 45.5  1.0 44.6  1.0
ody mass index (kg/m2) 25.3  0.3 25.5  0.2
p  0.05 compared with “None” group. †p  0.05 compared with “Mild” group. D
Figure 2. Erectile dysfunction by age.DBP and SBP  diastolic and systolic blood pressure, respectively; NS  not significaertriglyceridemia, obesity, and smoking) were performed
o detect independent associations for any ED or for
ncreasing severity of ED, after exclusion of the sexually
nactive group. Other than age, the statistically significant
ssociations were limited to hypercholesterolemia and obe-
ity. The model for any ED shows significant independent
redictors to be age (per year, odds ratio [OR] 1.09, 95%
onfidence interval [CI] 1.06 to 1.13; p  0.0001) and
ypercholesterolemia (OR 1.93, 95% CI 1.21 to 3.06; p 
.006). When this model included men who were not
exually active in the ED group, obesity (OR 2.02, 95% CI
.05 to 3.89; p  0.035) was also a significant independent
redictor, in addition to age (per year, OR 1.12, 95% CI
.09 to 1.16; p  0.0001) and hypercholesterolemia (OR
.76, 95% CI 1.12 to 2.74; p 0.014). In a cumulative logit
odel, age (per year, OR 1.07, 95% CI 1.04 to 1.09; p 
.0001), presence of hypercholesterolemia (OR 1.54, 95%
I 1.05 to 2.26; p  0.027), and obesity (OR 1.93, 95% CI
.18 to 3.17; p  0.009) were each independent significant
redictors of a stepwise increase in severity of ED.
The results from a separate multivariate analysis limited
o men who were 50 years of age at baseline were similar
o the results from the entire cohort in terms of age (OR
.07, 95% CI 1.02 to 1.12; p  0.005) and hypercholester-
lemia (OR 1.88, 95% CI 1.15 to 3.08; p  0.012), each
ignificant independent predictors of any ED.
Finally, to determine whether men with more than one
isk factor would have an increased risk of ED, we examined
he frequency of any ED by the number of risk factors. At
aseline, 21% of men had no categorically defined risk
actors, 33% had one, 26% had two, and 20% had three or
ore risk factors. In men who had only one risk factor, high
holesterol was the most common single factor (55.8%),
ollowed by current smoking (16.5%), hypertension
11.2%), obesity (8%), diabetes (7.4%), and high triglycer-
des (1.1%). For men with two risk factors, the most
ommon combinations were high cholesterol and current
moking (32%) and high cholesterol and hypertension
26%). For men with three risk factors, the most common
ombination was high cholesterol, current smoking, and
Dysfunction Category for Men in the Rancho Bernardo Study,
of Erectile Dysfunction
erate
70)
Severe/
Complete
(n  72)
Not Sexually
Active
(n  180)
Test for
Trend
 1.2 46.5  1.0 51.5  0.7 0.00001
 0.1 5.8  0.1 6.0  0.1 NS
 0.1* 5.3  0.1 5.3  0.1 NS
.3 1.4* 1.4*† 0.01
 1.6 123.2  1.6 121.2  1.1 NS
 1.2 78.8  1.1 77.1  0.8 NS
 1.2 44.4  1.2 44.1  0.8 NS
 0.3 26.1  0.3* 26.0  0.2* 0.05
e presented as the mean value  SE.ctile
egory
Mod
(n 
46.7
5.8
5.5
1
123.0
78.5
44.5
25.7
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April 21, 2004:1405–11 CHD Risk Factors Predict EDigh triglycerides (16%); a similar proportion (15%) had
igh cholesterol, hypertension, and obesity. In an age-
djusted analysis with no risk factors set as the referent OR
f 1, there was a linear trend toward increasing risk of any
D by number of risk factors; the ORs of ED were 1.50,
.72, and 2.20 for men with one, two, or three or more risk
actors, respectively.
ISCUSSION
o our knowledge, this is the only long-term, population-
ased, prospective study of mid-life CHD risk factors and
ubsequent ED. In this cohort of community-dwelling men,
ommon CHD risk factors (age, BMI, current smoking,
igh BP, and high cholesterol and triglyceride levels) 25
ears earlier predicted an increased risk and severity of ED
nd/or sexual inactivity. The 25-year 68% response rate
mong survivors was less than the 77% response rate after
ine years of follow-up in Massachusetts Male Aging Study
MMAS) (17), the only other published prospective study
f multiple CHD risk factors and ED. The risk factor
ssociations observed in the Rancho Bernardo cohort are
ikely to have been underestimated because the men who did
ot survive the 25 years to the ED questionnaire had
ignificantly less favorable levels of all CHD risk factors at
aseline.
ge. Age is the best-established risk factor for the devel-
pment and severity of ED, as reported first by Kinsey et al.
18) in 1948, with 25% of 65-year-old men and up to 75%
f men age 80 years reporting ED. Modern cross-
ectional prevalence and incidence studies have shown
imilar age-related trends (4,6,7,9). We previously reported
hat the prevalence of ED in the Rancho Bernardo cohort
ncreased from 16% in men 50 years of age to more than
1% in men age 70 years (19). Although ED was not
ueried at baseline, two-thirds of the men reported here
ere 50 years of age at baseline, when moderate or severe
D would be unusual. (Furthermore, analyses restricted to
en age 50 years at baseline showed similar results.)
onsistent with their relatively young age at baseline, only
.6% reported heart disease and 2.1% reported a history of
iabetes, 40% of whom were sexually inactive 25 years later.
eight. Obesity was a strong predictor of ED, with the
ge-adjusted BMI significantly higher in men with later
eported severe/complete ED or who were sexually inactive.
n multivariate analysis, obesity remained a significant
ndependent predictor of increasingly severe ED. Although
besity is associated with generally accepted ED risk factors,
uch as diabetes, hyperlipidemia, and hypertension, surpris-
ngly few community-based studies have reported weight as
n independent risk factor for ED (6,7). Although the
riginal cross-sectional MMAS (4) did not show a signifi-
ant association between BMI and ED, the nine-year
ollow-up study (17) reported that a BMI 28 kg/m2
redicted incident ED (OR 1.96, p  0.01), similar to our
esults. In a separate prospective MMAS report, baseline lbesity defined as BMI 30 kg/m2 was associated with a
igher risk of ED, despite any subsequent weight loss. In
MAS, a sedentary lifestyle, not studied in the Rancho
ernardo cohort at baseline, also predicted a higher risk of
D (20). On average, men in MMAS were more over-
eight (BMI of 27.5 kg/m2) than the men at Rancho
ernardo (BMI of 25.7 kg/m2) (4).
ipids. In the present study, high fasting plasma choles-
erol and triglyceride levels were significant risk factors for
ore severe ED. On multivariate analysis, categorically
efined hypercholesterolemia was a strong independent
redictor of any ED and of a stepwise graded association for
ncreasingly severe ED. Hypercholesterolemia was the most
ommon risk factor in men with only a single risk factor
present in 55%) and was present in most men who had
ore than one risk factor—85% of men with two risk
actors and 87% of men with three risk factors.
Cholesterol was also an ED risk factor in a 22-month
ollow-up study of 3,250 men age 25 to 83 years seen in
reventive medicine clinics; in this study, each mmol/l
ncrease in baseline total cholesterol was associated with
.32 times the risk of ED (21). In contrast, in the MMAS
rospective study, total cholesterol did not predict future
D, and triglycerides were not measured (17). The signif-
cant predictive role of hypercholesterolemia with ED at
ancho Bernardo may reflect the participants’ younger age
t baseline, longer duration of follow-up, or the nearly
omplete absence of lipid-lowering medication use at base-
ine from 1972 to 1974.
moking. Cross-sectional studies have reported that smok-
ng is an independent risk factor for ED (4,22,23). For
xample, a study that excluded diabetic patients and con-
rolled for age, trauma history, and hypertension found
moking to be independently associated with atherosclerosis
n the internal pudendal artery (p  0.05); the relative risk
or each 10 pack-years smoked was 1.31 (23). In a meta-
nalysis of 19 studies, Tengs and Osgood (24) reported that
0% of impotent men were current smokers, compared with
8% of men in the general population. In the Rancho
ernardo Study, with 25% of men being current smokers at
aseline, current smoking at baseline was marginally more
ignificant in men with severe/complete ED in an age-
djusted model, but was not an independent predictor of
D in the multivariate models. Nearly all surviving Rancho
ernardo men had quit smoking some time before the
ollow-up questionnaire. A prospective study of heavy
mokers noted improvement in penile tumescence and
igidity within one month of smoking cessation (25). Thus,
he minimal association of ED and smoking likely reflects
he selective survival of men who had successfully discon-
inued their habit and lived to complete the follow-up
uestionnaire.
lood pressure. Hypertension clinics report a high preva-
ence of ED (26,27). Men in the Treatment of Mild
ypertension Study with SBP 140 mm Hg were twice asikely as men with SBP 140 mm Hg to report erectile
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CHD Risk Factors Predict ED April 21, 2004:1405–11roblems (28). The prospective MMAS (17) reported a
orderline significant (p  0.06) association of ED with
ypertension, applying the same definition used in the
resent study. In the Rancho Bernardo cohort, neither
ategorical hypertension nor BP measurements significantly
redicted moderate or severe ED 25 years later. Most men
ere classified as hypertensive based on elevated SBP and/or
BP. Only 30 men were classified as hypertensive based on
istory alone (i.e., without confirmatory BP levels), 21 of
hom were taking BP medication. Thus, the majority of
hose classified as hypertensive had no history of hyperten-
ion. Either white-coat hypertension or misclassification,
eflecting the very high BP levels used to diagnose hyper-
ension in the 1970s, could have obscured a true association.
he 3.7% of Rancho Bernardo men who reported taking BP
edication at baseline is low compared with 19% of the
rospective MMAS cohort (17), which may have changed
he associations. Common antihypertensive medications are
ssociated with ED (29), but aggressive antihypertensive
herapy can aid in the recovery of erectile function in animal
odels (30).
iabetes. Erectile dysfunction is said to follow within 10
ears of the diagnosis of diabetes mellitus in at least 50% of
en and may be the presenting manifestation of diabetes in
0% to 15% (31). Surprisingly, diabetes as a risk factor for
D has not been evaluated prospectively in a population,
nd the lag time between the onset of diabetes and the
ncreased risk of ED is unknown. There is some evidence
hat ED commonly precedes the diagnosis of diabetes (32).
revious studies of the relationship between ED and dia-
etes or glycemia are retrospective or cross-sectional (4–7).
n the MMAS cross-sectional study, men with a history of
reated diabetes had at least a threefold risk of ED (4), but
either diabetes nor hyperglycemia was reported in the
rospective study of cardiovascular risk factors (17).
Neither diabetes nor FPG was significantly associated
ith incident ED in the Rancho Bernardo Study, although
2% had diabetes, most defined by fasting hyperglycemia
126 mg/dl [7.0 mmol/l]) at baseline. Only 12 men (2.1%)
ave a history of diabetes in the period from 1972 to 1974,
ine of whom did not have fasting hyperglycemia. When
hese baseline data were obtained (1972 to 1974), screening
or diabetes was uncommon; known diabetes was more
ommon (7%) in the 1987 to 1989 MMAS (4). Post-
hallenge glucose levels, which are more sensitive than
asting glucose for the diagnosis of diabetes in older adults
33), were not measured in Rancho Bernardo at baseline.
en with higher levels of FPG were less likely to survive
he 25-year follow-up to the ED questionnaire. Also, within
he 25-year follow-up period, other study participants prob-
bly developed diabetes. Thus, a combination of a low
revalence of known diabetes at baseline, misclassification,
nd survivor bias may explain the absence of the expected
ssociation between diabetes and ED. Alternatively, because
lycemic control may be inversely associated with the levelf ED (34), careful management of diabetes in the educated
ancho Bernardo cohort could have reduced the risk of ED.
tudy limitations. The Rancho Bernardo cohort is a ho-
ogeneous group of older, educated, middle-class to upper
iddle-class Caucasian men. Therefore, the associations or
ack of associations reported here may not apply to other
ocioeconomic or ethnic groups. The prevalence of ED in
ancho Bernardo was similar to that reported in the other
arge Caucasian cohort (4). The 25-year follow-up is an
dvantage in assessing mid-life exposure to common CHD
isk factors but allows unknown interval risk factor changes
o obscure associations and does not consider new medica-
ions, psychological states, or comorbidities. Men in the ED
ohort had significantly more favorable levels of all CHD
isk factors measured than decedents, thus introducing a
onservative bias and reducing the ORs toward the null.
urvival bias does not negate the relevance of the results,
ecause it is the survivors who live long enough to develop
D.
Although Rancho Bernardo medical and medication
istories were self-reported, only 30 men were classified as
ypertensive based on history without confirmatory BP
evels, only eight men were classified as diabetic based on
istory without confirmatory plasma glucose levels, and only
4 men were classified as hypercholesterolemic without
onfirmatory plasma cholesterol levels. Furthermore, at
aseline, only 6% of the entire cohort was being treated with
edication for one of these risk factors.
Although the IIEF-5 is a convenient, validated screening
ool to define ED in populations (14,15,35), all five ques-
ions must be answered for ED classification. According to
rotocol, men without recent sexual activity for any reason
annot be classified. In the Rancho Bernardo Study, sexually
nactive men had CHD risk profiles and increased comor-
idities similar to those of men with severe/complete ED.
his suggests that severe ED will be underestimated by
xcluding sexually inactive men (31% of respondents in this
tudy), in that ED may be a prominent reason for sexual
nactivity.
onclusions. The CHD risk factors measured in mid-life,
ncluding age, current cigarette smoking, obesity, hypercho-
esterolemia, and hypertriglyceridemia, were associated with
ncident ED 25 years later. This long interval allows time
or modification of CHD risk factors, which could decrease
he risk of ED as well as CHD. To test this hypothesis, ED
hould be included as an outcome in future CHD preven-
ion trials.
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